{"id":209836,"name":"CIGNA CORPORATION AND SUBSIDIARIES","slug":"cigna-corporation-and-subsidiaries","state":"DC","country":"United States of America","description":"Employee benefits company.","totalSpending":1710000,"filings":20,"yearlySpending":[{"year":2021,"income":270000},{"year":2022,"income":360000},{"year":2023,"income":360000},{"year":2024,"income":360000},{"year":2025,"income":360000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"},{"code":"HCR","display":"Health Issues"},{"code":"DEF","display":"Defense"}],"firms":["TIBER CREEK GROUP"],"lobbyists":["ANDREW MCKECHNIE","JAMES HEIMBACH","ASHLI PALMER","JOHN TWOMEY","TIMOTHY ROBINSON","JAN BEUKELMAN","NIKOLE BURROUGHS","JOSEPH RUSSO"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","White House Office"],"sampleDescriptions":["Proposals that impact Medicare Part D and ongoing implementation of payment and regulatory issues for the Medicare Advantage program.","Issues impacting insurance coverage, prescription drugs and the federal COVID response; Issues related to importation of prescription drugs.","Proposals that impact Medicare Part D and ongoing implementation of payment and regulatory issues for the Medicare Advantage program.","Issues impacting insurance coverage, prescription drugs and the federal COVID response.","Proposals that impact Medicare Part D and ongoing implementation of payment and regulatory issues for the Medicare Advantage program; S. Con Res 14 and the impact on the expansion of Medicare benefits"]}